Blog

Laura Bukavina: The use of TMT for localized bladder cancer in octogenarians

Laura Bukavina/X

Dec 19, 2024, 07:51

Laura Bukavina: The use of TMT for localized bladder cancer in octogenarians

Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology and Associate Editor of European Urology, posted the following on X:

“The use of TMT for localized bladder cancer in octogenarians has surged from 53.5% in 2004 to 82.2% in 2021. However, cancer-specific mortality (CSM) higher with TMT compared to RC (50.1% vs 31.1%), with TMT independently predicting a 1.7-fold increased CSM risk.”

Survival after trimodal therapy in octogenarians with organ-confined urothelial bladder cancer

Authors: Mattia Longoni, Francesco Di Bello, Natali Rodriguez Peñaranda, Fabian Falkenbach, Andrea Marmiroli, Quynh Chi Le, Zhe Tian, Jordan A. Goyal, Nicola Longo, Salvatore Micali, Markus Graefen, Gennaro Musi, Felix K. H. Chun, Fred Saad, Shahrokh F. Shariat, Marco Moschini, Giorgio Gandaglia, Francesco Montorsi, Alberto Briganti, Pierre I. Karakiewicz

Alberto Briganti Andrea Marmiroli cancer Fabian Falkenbach Felix K. H. Chun Francesco Di Bello Francesco Montorsi Fred Saad Gennaro Musi Giorgio Gandaglia Jordan A. Goyal Marco Moschini Markus Graefen Mattia Longoni Natali Rodriguez Peñaranda Nicola Longo OncoDaily Oncology Pierre I. Karakiewicz Quynh Chi Le Salvatore Micali Shahrokh F Shariat Zhe Tian

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage